Moreover, more sophisticated gene-gene and gene-environment interactions should also be considered in further analyses, which should lead to a better, comprehensive understanding of the association between the CYP17 T27C polymorphism and prostate cancer risk. This evidence concerns the gene CYP17A1 and prostate carcinoma.